Claudio Bellevicine (@pathologyfinder) header
Claudio Bellevicine (@pathologyfinder) profile picture

Papers, interesting cases and discussion topics on Surgical Pathology, Cytopathology and Molecular Pathology. Claudio Bellevicine, MD, PhD. #cytopath #pathology

Napoli, Italia
Joined October 2012
✨XV Molecular Cytopathology Meeting!✨ 📅 9–10 December 2026 📌 Naples, Italy 👨‍🔬 Meeting Director and EiC of #JMPMDPI: Giancarlo Troncone 👩‍🔬 Meeting Co-Chairs: Sinchita Roy-Chowdhuri, Associate Editor of #JMPMDPI, and Maria D. Lozano, EBM of #JMPMDPI molecularcytopathology.net/
8
1
13
642
Published in Acta Cytologica: 7-gene mutation panel performance in oncocytic vs non-oncocytic Bethesda IV thyroid nodules. A positive result was significantly associated with malignancy only in non-oncocytic nodules. doi.org/hcn9x7 #cytopath #thyroid #FNA
3
5
383
Claudio Bellevicine retweeted
#ECC2026 Well attended Thyroid Session @CanberkSule @pathologyfinder
4
27
718
Claudio Bellevicine retweeted
#ECC great thyroid session with excellent presentation by Canberk, Bellvicine, Hu and Fadda
6
19
734
#ECCyto2026 is starting tomorrow (4 October 2026) with our #IACcompanionmeeting! Looking forward to seeing you all there: 15:45 at Tiffany room - 2nd floor, Hilton Antwerp Belgium.
2
12
25
831
Claudio Bellevicine retweeted
#IACwebinar Join us this Friday, 25 September 2026 for: “Pancreatic #Cytopathology: New WHO Classification — An Update” 🎙️ Asif Loya, MD 🕑 2:00 PM CEST | 5:00 PM PKT 🔒 IAC members only — pre-registration required. #Pancreas #WHOClassification #Pathology #EUSFNAC
1
4
1
9
901
Claudio Bellevicine retweeted
⭐️🧬 Call For Abstracts 🧬⭐️ 🔊 Path trainee and junior/early-in-practice pathologists 🔬Submit an abstract for a platform presentation 💗 XV Molecular Cytopathology Meeting on Dec 9-10, 2026, Naples molecularcytopathology.net/ Deadline: Oct 1 app.concertosrl.net/Public/A… #MolCytoPath
15
1
32
5,769
New in Virchows Archiv: Nexthyro 2.0, our custom NGS panel combining DNA mutation + RNA fusion profiling for thyroid pathology. 100% success on FFPE tissue, 95.3% on FNA, sensitivity to 0.5% VAF. Open access: doi.org/10.1007/s00428-026-0… #ThyroidCancer #NGS #Pathology
4
9
246
Claudio Bellevicine retweeted
"A tapestry woven in mucin." The artistic appearance of thick (crystallized) mucin aspirated from a neoplastic mucinous cyst of the pancreas. (EUS-FNA)
1
16
75
1,943
Claudio Bellevicine retweeted
✉️ New Letter to the Editor | Supernatant: What’s in a name? Without a gold standard for supernatant preparations, molecular results hardly can be compared across studies, affecting their reproducibility. acsjournals.onlinelibrary.wi… #CytoPath @Sinchita_Roy @pathologyfinder
4
2
11
1,794
Dear #IACmembers, here is a kind reminder to preregister for this #IACwebinar: Biomarker Testing in Lung Cytopathology: The Past, The Present, & The Future by Prof. @Sinchita_Roy on 21 May at 15:00 CEST (08:00 AM CDT) cytology-iac.org/educational…
1
11
1
24
783
Claudio Bellevicine retweeted
“Dreams do come true.” During the recently concluded Asian Federation of Cytology Societies (AFCS) inaugural congress in Hong Kong, many people asked me how all of this happened - how we achieved such success so quickly. My answer was simple: it was neither quick nor easy. It took many years of vision, persistence, and collective effort. Over the last 25 years, I have made more than 75 trips to East Asia. During those visits, I repeatedly recognized the need for a consortium where national cytology societies across Asia could pool their talent, resources, and expertise, while also supporting smaller and resource-limited countries. The ultimate vision was to create a unified annual congress in which every Asian national society could participate, alongside distinguished faculty from other regions of the world, including the United States and Europe. About 10 years ago, I began discussing this idea with many Asian friends and colleagues. While everyone supported the concept enthusiastically, there was understandable skepticism about how such an ambitious vision could ever become reality. Years passed before I finally received a lucky break. About three years ago, I presented a rough plan to my close friends, Drs. Gary Tse and Bob Osamura, both of whom became instrumental in supporting the founding of AFCS. The name “AFCS” itself was finalized after I discussed the concept with Dr. Danijela Vrdoljak-Mozetic, secretary-general of the EFCS, as the mission statements of the two federations were remarkably aligned. It then took nearly a year of countless WhatsApp calls by me with many individuals across Asia, seeking support to enlist their national organizations as companion societies under the AFCS umbrella. Once our list grew to 20 countries, I felt the time was right to formally announce the launch of AFCS at the International Congress of Cytology in Florence, Italy in May 2025. That became a pivotal moment in our journey. Soon afterward, the executive council was established. Upon my strong recommendation, Bob Osamura was approved as the first President of AFCS, and Gary Tse as the Secretary-General, with Hong Kong selected as the federation headquarter and venue for the historic inaugural congress. Dr. Jamal Musayev from Baku designed the eye-catching insignia. The orange color symbolizes the warmth and optimism of Asia, with rays of sunlight reflecting hope, unity, and a bright future. Those who attended the recent congress witnessed firsthand the extraordinary work accomplished by Dr. Gary Tse and his remarkable team. Congratulations to them - and to everyone who contributed their time, effort, and expertise to this historic success. As the congress concluded, I finally allowed myself a quiet sigh of relief. A dream that once seemed distant had finally come true. As Ryūnosuke Satoro, a Japanese poet and philosopher so beautifully said: “Individually, we are one drop. Together, we are an ocean.” Today, with more than 20 national societies united together, we have created that mighty ocean - visible, collaborative, impactful, and full of promise for the future of cytopathology across Asia and beyond. @cytopathology @IACytology @CytologyEFCS @JM_CytoBox @MozeticV
14
22
5
90
5,243
Happy #InternationalCytologyDay coined after G. Papanikolaou. Did you know that his wife Mary Papanicolaou, played a vital role in the history of cytology? She provided vaginal fluid samples every day for 21 yrs, processed & stained her own samples cytology-iac.org/membership-…
16
30
675
For this #WorldBookDay we strongly recommend the IAC-@IARCWHO Cytopathology Reporting Systems Books. Together, we continue working on classifying tumours. These books are an essential tool for standardising diagnostic practice worldwide #cytopath publications.iarc.who.int/Bo…
22
1
32
1,931
Claudio Bellevicine retweeted
XV Molecular Cytopathology Congress 📣 SAVE THE DATE 🗓️ 9-10 December 🎄 ✨ 📍Naples 🇮🇹 #cytopath #cytology #Cytopathworldwide #cytolovers 📚 🔬 🍕 🌊 👀 ☀️ @aakasharmand @AMPath @PVielh @SECitologia @SFCCFrance @ACitopatologia @spcitologia @hkiap1986 @CytopatholKorea
13
1
22
1,599
Claudio Bellevicine retweeted
Dear #IACmembers, preregister now for this spectacular #IACwebinar hosted by @Sinchita_Roy on 21st May at 03:00 PM CEST: Biomarker Testing in Lung #Cytopathology: The Past, The Present, & The Future cytology-iac.org/educational…
9
24
1,163
Claudio Bellevicine retweeted
On a Friday! As a @IACytology member I have received Acta Cytologica journal. What an interesting issue about quality in cytology. Thanks for including FioNA, @pathologyfinder et al. 🙌🏾 Love the smell of a printed journal by the way 😅. #FNAFriday #CytoPath #Training #SimInPath
1
4
1
24
1,216